(Q40564224)

21 September 2017

title

Regions syntenic to human 17q are gained in mouse and rat neuroblastoma (English)

1 reference

21 September 2017

0 references

1

Maria Łastowska

1 reference

21 September 2017

Yeun-Jun Chung

2

1 reference

21 September 2017

Ngan Cheng Ching

3

1 reference

21 September 2017

Michelle Haber

4

1 reference

21 September 2017

Murray D Norris

5

1 reference

21 September 2017

Ursula R Kees

6

1 reference

21 September 2017

Andrew D J Pearson

7

1 reference

21 September 2017

Michael S Jackson

8

1 reference

21 September 2017

publication date

1 June 2004

1 reference

Genes, Chromosomes and Cancer

21 September 2017

published in

1 reference

21 September 2017

volume

40

1 reference

21 September 2017

issue

2

1 reference

21 September 2017

page(s)

158-163

1 reference

Effects of MYCN antisense oligonucleotide administration on tumorigenesis in a murine model of neuroblastoma

21 September 2017

cites work

1 reference

An increased NM23H1 copy number may be a poor prognostic factor independent of LOH on 1p in neuroblastomas

21 January 2018

1 reference

Gain of chromosome arm 17q and adverse outcome in patients with neuroblastoma

21 January 2018

1 reference

7 January 2021

Comparative genomic hybridization (CGH) analysis of neuroblastomas--an important methodological approach in paediatric tumour pathology

1 reference

7 January 2021

Clinical prognostic factors in 1277 patients with neuroblastoma: results of The European Neuroblastoma Study Group 'Survey' 1982-1992.

1 reference

7 January 2021

Successful management of low-stage neuroblastoma without adjuvant therapies: a comparison of two decades, 1972 through 1981 and 1982 through 1992, in a single institution

1 reference

7 January 2021

The N-myc and c-myc downstream pathways include the chromosome 17q genes nm23-H1 and nm23-H2.

1 reference

7 January 2021

High levels of p19/nm23 protein in neuroblastoma are associated with advanced stage disease and with N-myc gene amplification

1 reference

7 January 2021

Molecular analysis of chromosome arm 17q gain in neuroblastoma

1 reference

7 January 2021

Gain of chromosome arm 17q predicts unfavourable outcome in neuroblastoma patients. U.K. Children's Cancer Study Group and the U.K. Cancer Cytogenetics Group

1 reference

7 January 2021

Comprehensive genetic and histopathologic study reveals three types of neuroblastoma tumors.

1 reference

7 January 2021

Breakpoint position on 17q identifies the most aggressive neuroblastoma tumors

1 reference

7 January 2021

Additional copies of a 25 Mb chromosomal region originating from 17q23.1-17qter are present in 90% of high-grade neuroblastomas

1 reference

7 January 2021

Initial sequencing and comparative analysis of the mouse genome

1 reference

7 January 2021

Estimation of divergence times from multiprotein sequences for a few mammalian species and several distantly related organisms

1 reference

7 January 2021

Targeted expression of MYCN causes neuroblastoma in transgenic mice

1 reference

7 January 2021

Identifiers

DOI

10.1002/GCC.20031

1 reference

21 September 2017

1 reference